0
0
3/16/23 at 9:02pm
Organization
Gizmodo.com
Author
Ed Cara
31 words
0
Comments
About a third of patients with relapsed or refractory acute leukemia experienced complete remission after taking the drug, known as revumenib.
1 similar article
You are the first to view
https://gizmodo.com/revumenib-shows-promise-against-leukemia-in-early-trial-1850234770
Create an account
or login to join the discussion